Explore expert-vetted resources on diseases of mind and sight.
Dr. Michelle Papka gives insights into how to participate in trials that are currently open for enrollment across the US.
What new technologies for diagnosing cognitive disorders are on the horizon? Join Dr. Michael Weiner, a leading expert in neuroimaging and biomarkers, as he explores advancements in digital and voice assessments, MRI, PET scans, and blood-based tests.
Join our conversation with Dr. Rudolph Tanzi as he explains how stopping Alzheimer’s disease will require a combination of early detection using blood biomarkers, presymptomatic intervention with safe and affordable therapies, and lifestyle modifications.
Join our conversation with Dr. Jeffrey L. Cummings, renowned expert in dementia drug development and research studies, for insights into the different types, qualification processes, and phases of studies that may be right for you or your loved one.
Join us as lead scientist Dr. Miia Kivipelto discusses the science behind lifestyle interventions for reducing Alzheimer’s risk.
Learn about the Bio-Hermes-002 study exploring blood and digital biomarkers for predicting Alzheimer’s pathology. Discover accessible detection methods and treatment eligibility.
